NCT00003572
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +46 more
- Locations
-
- Johns Hopkins Oncology Center Baltimore, Maryland, United States
Clinical trial condition
Leukemia, B-Cell
Explore clinical trials studying Leukemia, B-Cell. Study availability and eligibility vary by location and protocol.
1,389 public trials
159 recruiting studies
Leukemia, B-Cell trial results
Completed
Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
NCT00003962
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +50 more
- Locations
-
- Johns Hopkins Oncology Center Baltimore, Maryland, United States
NCT01231919
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Acute Leukemias of Ambiguous Lineage, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, +130 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Childrens Hospital of Orange County Orange, California, United States
- University of California San Francisco Medical Center-Parnassus San Francisco, California, United States
- Children's National Medical Center Washington D.C., District of Columbia, United States
Completed
Bryostatin 1 Plus Cladribine in Treating Patients With Relapsed Chronic Lymphocytic Leukemia
NCT00003174
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
- Locations
-
- Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
- Josephine Ford Cancer Center at Henry Ford Hospital Detroit, Michigan, United States
- Van Elslander Cancer Center at St. John Hospital and Medical Center Grosse Pointe Woods, Michigan, United States
NCT01161511
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
- Locations
-
- Medical College of Georgia Augusta, Georgia, United States
- The Ohio State University Columbus, Ohio, United States
- Sarah Cannon Research Institute Nashville, Tennessee, United States
NCT00265837
- Conditions
- Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +64 more
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
NCT00724984
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +24 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
- Northwestern University Medical School Chicago, Illinois, United States
- Horizon Oncology Center Lafayette, Indiana, United States
- University of Massachusetts Medical School Worcester, Massachusetts, United States
NCT01246557
- Conditions
- Chronic Disease, Chronic Lymphatic Leukemia, Disease Attributes, +14 more
- Locations
-
- Centro Médico Teknon Barcelona, Spain
- Hospital de la Santa Creu i Sant Pau Barcelona, Spain
- Hospital Universitari Valle Hebron Barcelona, Spain
- Hospital Clinico Universitario de Barcelona Barcelona, Spain
NCT01233921
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +151 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
Completed
Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy
NCT00890747
- Conditions
- AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, +199 more
- Locations
-
- Jonsson Comprehensive Cancer Center Los Angeles, California, United States
- Lombardi Comprehensive Cancer Center at Georgetown University Washington D.C., District of Columbia, United States
- Northwestern University Chicago, Illinois, United States
- AIDS - Associated Malignancies Clinical Trials Consortium Rockville, Maryland, United States